SCHEMBL24993563

SCHEMBL24993563

CCOc1ccc(-c2cnc(-c3ccccc3)c(C(=O)NN)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ NPC1 O15118 2/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ ATR Q13535 4/20 0.48
▸ PRKDC P78527 3/20 0.48
▸ SCN2A Q99250 3/20 0.47
▸ SCN10A Q9Y5Y9 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ AURKA O14965 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ DGAT1 O75907 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24993550 0.87 NPC1 (0.52) MAPTKDM4ENPC1ALDH1A1ATR
SCHEMBL24993566 0.84 ALDH1A1 (0.49) MAPTKDM4ENPC1ALDH1A1ATR
SCHEMBL24993561 0.83 ALDH1A1 (0.55) MAPTKDM4ENPC1ALDH1A1ATR
SCHEMBL24993560 0.82 ALDH1A1 (0.54) MAPTKDM4ENPC1ALDH1A1ATR
SCHEMBL24993559 0.81 ALDH1A1 (0.53) MAPTKDM4ENPC1ALDH1A1ATR
SCHEMBL24993638 0.79 ALDH1A1 (0.52) MAPTKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL25003805 0.75 ALDH1A1 (0.57) MAPTKDM4ENPC1ALDH1A1SCN2A
SCHEMBL3461301 0.75 ATR (0.57) ATRPRKDC
SCHEMBL3461372 0.74 ATR (0.74) ATRPRKDC
SCHEMBL24993306 0.74 SCN10A (0.69) MAPTKDM4ENPC1ALDH1A1SCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010191-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback